Inventor · disambiguated record
Stanley Jordan
Also filed as: JORDAN STANLEY · JORDAN STANLEY C
5 granted patents·14 pending applications·15 citations·filing 1994–2025
71Inventor score
Top patents by PatentIndex Score
19 records- 0177US11149091B2Methods for treating nephrotic syndromeCEDARS SINAI MEDICAL CENTER·Filed 2016·Granted Oct 19, 2021·3 cites·26 claims
- 0273US2024218072A1Methods for treating nephrotic syndromeCEDARS SINAI MEDICAL CENTER·Filed 2023·Application pending·0 cites
- 0370US2025000958A1Methods for improving organ function in organ transplant patientsCEDARS SINAI MEDICAL CENTER·Filed 2024·Application pending·0 cites
- 0468US11840576B2Methods for treating nephrotic syndromeCEDARS SINAI MEDICAL CENTER·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 0562US2024124573A1Use of Anti-Il-6 Antibody, e.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (ABMR)VITAERIS INC·Filed 2023·Application pending·0 cites
- 0659US12059456B2Methods of using C1 esterase inhibitor for improving early onset and long-term function of kidney transplants from grafts associated with delayed graft functionCEDARS SINAI MEDICAL CENTER·Filed 2018·Granted Aug 13, 2024·0 cites·7 claims
- 0758US2025263480A1Clazakizumab in the Treatment of Chronic Antibody-Mediated Rejection of Organ TransplantCEDARS SINAI MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 0858US2025340618A1Method for Treating Antibody-Mediated Rejection Post-TransplantationCEDARS SINAI MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 0955US2024050541A1Intra-renal infusions of c1 inhibitor prior to transplantation of allografts to reduce delayed graft function and ischemia/reperfusion injury and to improve long-term graft functionCEDARS SINAI MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 1050US6171585B1IVIg immunosuppression in HLA-sensitized transplant recipientsCEDARS SINAI MEDICAL CENTER·Filed 1994·Granted Jan 9, 2001·12 cites·18 claims
- 1149US2017174760A1Method for treating antibody-mediated rejection post-transplantationCEDARS SINAI MEDICAL CENTER·Filed 2017·Application pending·0 cites
- 1248US2022073605A1Clazakizumab in the treatment of chronic antibody-mediated rejection of organ transplantCEDARS SINAI MEDICAL CENTER·Filed 2019·Application pending·0 cites
- 1347US2022288202A1Use of Calcineurin Inhibitor Free CTLA4-IG + Anti-IL6/IL6R For Long Term Immunosuppression in Solid Organ Transplant RecipientsCEDARS SINAI MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 1446US2022265786A1Methods of improving organ functionCEDARS SINAI MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 1544US2022135695A1Anti-cd38 agents for desensitization and treatment of antibody-mediated rejection of organ transplantsCEDARS SINAI MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 1644US2021395358A1Use of clazakizumab to desensitize and improve renal transplantation in hla-sensitized patientsCEDARS SINAI MEDICAL CENTER·Filed 2019·Application pending·0 cites
- 1743US11865175B1Post-transplantation prophylaxis and treatments for antibody-mediated rejection of solid organ transplantCEDARS SINAI MEDICAL CENTER·Filed 2018·Granted Jan 9, 2024·0 cites·20 claims
- 1842US2021070853A1Use of Anti-Il-6 Antibody, e.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (ABMR)VITAERIS INC·Filed 2019·Application pending·0 cites
- 1933US2017022280A1Method for treating antibody-mediated rejection post-transplantationCEDARS SINAI MEDICAL CENTER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stanley Jordan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →